Concepedia

Author

Arin McKinley

Portland VA Medical Center

Also Known As

Arin McKinley, Arin Mckinley

12

Publications

1.8K

Citations

7

H-Index

5

Concepts

All Affiliations

Portland VA Medical CenterOregon Health & Science UniversityBrigham and Women's HospitalDana-Farber Cancer InstituteHarvard University
AM

About

Arin McKinley is an author at Portland VA Medical Center specializing in drug discovery, systems biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

270

2

Pharmacology

1

1

270

3

Drug Discovery

1

1

270

4

Systems Biology

1

1

270

5

Tumor Biology

1

1

270

Arin McKinley

×

7

Publications

1.8K

Citations

7

H-Index

YearCitations

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

Michael C. Heinrich, Robert G. Maki, Christopher L. Corless,

Journal of Clinical Oncology

2008

799

Ripretinib (DCC-2618) Is a Switch Control Kinase Inhibitor of a Broad Spectrum of Oncogenic and Drug-Resistant KIT and PDGFRA Variants

Bryan D. Smith, Michael D. Kaufman, Wei-Ping Lu,

Cancer Cell

2019

270

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

Michael C. Heinrich, Diana Griffith, Arin McKinley,

Clinical Cancer Research

2012

218

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

Michael C. Heinrich, Heikki Joensuu, George D. Demetri,

Clinical Cancer Research

2008

212

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

César Serrano, Adrián Mariño‐Enríquez, Derrick L. Tao,

British Journal of Cancer

2019

159

Multiplex Mutation Screening by Mass Spectrometry

Carol Beadling, Michael C. Heinrich, Andrea Warrick,

Journal of Molecular Diagnostics

2011

81

Sorafenib Inhibits Many Kinase Mutations Associated with Drug-Resistant Gastrointestinal Stromal Tumors

Michael C. Heinrich, Adrián Mariño‐Enríquez, Ajia Presnell,

Molecular Cancer Therapeutics

2012

76

Page 1